Plunkett Research Online: Clinuvel Pharmaceuticals Ltd.

CLINUVEL PHARMACEUTICALS LTD. (CLVLY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Clinuvel Pharmaceuticals Limited is a biopharmaceutical company developing its photo-protective drug, SCENESSE (afamelanotide), as a preventative treatment for a range of UV-related skin disorders as well as cancer related treatments. It conducts clinical trials on skin disorders using SCENESSE dru.....



Clinuvel Pharmaceuticals Ltd.
Ticker: CLVLY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 61 396604900
Fax: 61 396604999
Address: 15 Queen Street
Level 6
Melbourne, VIC 3000 Australia

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription

Clinuvel Pharmaceuticals Limited is a biopharmaceutical company developing its photo-protective drug, SCENESSE (afamelanotide), as a preventative treatment for a range of UV-related skin disorders as well as cancer related treatments. It conducts clinical trials on skin disorders using SCENESSE dru.....See More See More

Auditor: Grant Thornton
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: